Caya

Alternative Name: SILCS Diaphragm

Description: A one-size-fits-most silicone barrier method.

Product Details

User: Female

Hormonal: No

Delivery Method: Barrier

Duration Type: Short-acting, Pericoital

Duration: Single use

Regimen:
  • single

Inactive material: silicone

Multipurpose Preventive Technology (MPT): Yes

Status Details

Developer: PATH, CONRAD, SILCS, Inc., Kessel Marketing & Vertriebs GmbH

Project Phase: Limited Market Availability

Development Stage: SRA/WHO PQ Approved

Active Development: Yes

Status Details:
  • Received US FDA approval in 2014. Marketed in more than 20 countries. Available throughout Europe and in Canada.

Additional Information

References:
  • PATH website: http://www.path.org/news/press-room/688/

  • Product website: https://www.caya.eu/en/

  • Beksinska M, Greener R, Smit J, Maphumulo B, Mphili N, Kilbourne-Brook M, Coffey PS. (2018). A randomized crossover study evaluating the use and acceptability of the SILCS diaphragm compared to vaginal applicators for vaginal gel delivery. AIDS Behavior. 22(1):127-132.

Vertical Tabs

Print